ABSTRACT. Extracellular volume can be estimated from the distribution volume of sucrose (Vdsucrose). The purpose of this study was to establish sucrose pharmacokinetics in preterm infants e l 5 0 0 g compared to children and adults and to define an optimal sampling scheme. In five preterm infants, 10 children, and five adults Vdsucrose after a single injection was calculated with the two-compartment model (Vdsucrose-TCM) and with the one-compartment model applied only to the elimination phase of the same concentration-time curve (Vdsucrose-OCM). In preterm infants Vdsucrose-TCM was 417 f 45 mL/kg (mean + SD). V d~~~r O~e -O C M was only 3.0 2 2.3% higher, because sucrose elimination half-life was on average 250 times longer than distribution half-life. Therefore Vdsucrose-OCM, requiring only four blood samples between 2 to 5 h after injection, gave an adequate estimate of Vdsucrose in preterm infants e l 5 0 0 g. Vdsucrose-TCM in children and adults was 188 + 26 and 189 f 1 7 mL/kg, respectively. Vdsucrose-OCM was 10 to 65% higher. Therefore, in children and adults only Vdsucrose-TCM gives a reliable estimate of Vdsucrose. This requires 10 to 1 5 blood samples. The reduced sampling scheme was used in an extension of the study of preterm infants including five additional infants. Vdsucrose-OCM in the preterm infants was 462 + 47 mL/kg at birth and 425 f 46 mL/kg at maximal postnatal wt loss. Postnatal wt loss (mean -83 f 44 g) was not significantly different from postnatal reduction of Vdsucrose-OCM (mean -82 f 56 mL), suggesting that postnatal wt loss mainly represents extracellular fluid loss. (Pediatr Res 27: 256-259, 1990) Abbreviations Vdsucrose-TCM, distribution volume of sucrose calculated from the two-compartment model Vdsucrose-OCM, distribution volume of sucrose calculated from the one-compartment model
The knowledge of changes in extracellular volume of preterm infants is important for the understanding of the nature of postnatal wt loss and rational planning of parenteral nutrition. Previous studies of extracellular volume in preterm infants may be subject to criticism. First, they date from times of high volume fluid therapy (I). Second, sodium bromide, which was the most 2 frequently used indicator, is not confined to the extracellular space, but does enter cells (2) . Sucrose is a more adequate indicator, because it does not enter cells. Sucrose has been used in adults as an indicator of extracellular volume (3) (4) (5) (6) . The first pediatric study using sucrose was done in small-for-gestationalage preterm infants (7) . The authors assumed a mono-exponential concentration-time curve, but did not investigate sucrose pharmacokinetics in this particular patient population. Compared to children and adults, preterm infants have a large extracellular volume and a low glomerular filtration rate, which must affect sucrose disposition. The pharmacokinetics of sucrose in preterm infants have not been studied. To minimize the number of blood samples necessary, we evaluated the accuracy of calculating Vdsucrose with the one-compartment model applied only to the elimination phase of the concentration-time curve (Vdsucrose-OCM).
MATERIALS AND METHODS
Subjects. Sucrose distribution and elimination were studied in 10 preterm infants, 10 children, and five adults. Informed consent was obtained from each patient and/or the parents. The study was approved by the hospital's ethical committee.
Preterm infants. Ten preterm infants were studied during the first days of life. Their gestational age was 28 k 1.7 wk (mean + SD) and their birth wt was 1.1 + 0.1 kg (appropriate for gestational age). Infants were included in the study if they had an umbilical artery catheter inserted on clinical grounds. At the time of the investigation all infants required artificial ventilation. Exclusion criteria were gross edema, renal failure, cardiac failure, hypotension, and diuretic therapy. Infants were covered with a plastic blanket and nursed in incubators at thermoneutral temperature. Fluid therapy was directed according to our nursery guidelines, allowing for a wt loss up to 10% of birth wt. Each infant was studied within the first 12 h of life, and again when postnatal wt loss was approximately lo%, which occurred at an age of 86 & 10 h (mean + SD). The infants were given an injection of 2 mL/kg of a solution of sucrose (300 mmol/L). The exact amount given was determined by weighing the syringe before and after the injection and measuring the concentration and density of the indicator solution. In all infants blood samples (200 pL each) were taken before and at 120, 180, 240, and 300 min after injection (elimination phase). On five occasions we took additional early samples during the distribution phase at 2, 5, 10, 30, 60, 90 min after injection.
Children and adults. The children were 6.1 (3.4-12.1) (median, range) y of age; their wt was 22.2 (1 1.8-37.6) kg. The children were studied before the start of cytostatic therapy for various neoplasms. The adults were 21. The parameters of the bi-exponential function were determined from the concentration-time curve by curve-fitting using a nonlinear least-squares computer program (ENZFITTER by R.J. Leatherbarrow, London). The distribution volume (Vd-TCM) was calculated as follows:
where mi is the amount of indicator administered. The distribution half-life is In2/a, the elimination half-life is ln2//3.
The one-compartment model assumes instantaneous drug distribution over its final distribution volume. Data during the distribution phase are therefore disregarded and the elimination phase of the concentration-time curve is described by a monoexponential function:
where, co is the concentration at time 0, and k the elimination rate constant. The distribution volume (Vd-OCM) is:
When the elimination takes very long compared to the distribution, Vdsucrose-OCM gives an adequate estimate of the distribution volume. But when the elimination does not take much more time than the distribution, Vdsucrose-OCM overestimates the distribution volume (1 1, 12) . We compared Vd-TCM and Vd-OCM to evaluate this overstimation:
Statistics. Statistical analysis was performed by means of the Student's t test and regression analysis. Results were considered statistically significant when p < 0.05.
RESULTS
Sucrose pharmacokinetics in preterm infants. In five preterm infants the two-compartment model was used (Table 1) . Vdsucrose-TCM was 417 f 45 mL/kg (mean f SD). Elimination halflife was 250 times longer than distribution half-life, due to the very slow sucrose elimination (Fig. 1 a) . Therefore, Vdsucrose-OCM overestimated Vdsucrose-TCM by 3.0 2.3% (Fig. 2 ). Overestimation increased with increasing sucrose elimination for a longitudinal study in preterm infants. The mean reduction of Vdsucrose-OCM of 82 mL and the mean wt loss of 83 g did not differ significantly, suggesting that postnatal wt loss is fluid loss from the extracellular space. Shaffer et al. (26) found the same in preterm infants measuring bromide space. Postnatal increase in GFR was reflected in the concomitant increase in the fractional elimination rate constant of sucrose (Table 2) . This led to an increase of the overestimation of the distribution volume from d 1 to 3 and introduced a relative error of 2.7 + 2.3%, when comparing Vdsucrose-OCM of d 1 and 3.
Up to now the ideal indicator of extracellular volume has not been found and several different indicators are still advocated. Each presents specific problems and the results must be interpreted with great care. We presented data on sucrose, an indicator especially useful to measure the functional, readily exchangeable extracellular volume. A substantial reduction of the number of blood samples was possible in preterm infants allowing long term studies of V,sucrose even in this delicate group of patients.
